Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis.
Autor(es): Ehling Rainer; Pauli Franziska Di; Lackner Peter; Kuenz Bettina; Santner Wolfram; Lutterotti Andreas; Gneiss Claudia; Hegen Harald; Schocke Michael; Deisenhammer Florian; Berger Thomas; Reindl Markus
Resumo: Elevated plasma fibrinogen levels are a well known finding in acute infectious diseases, acute stroke and myocardial infarction. However its role in the cerebrospinal fluid (CSF) of acute and chronic central (CNS) and peripheral nervous system (PNS) diseases is unclear. We analyzed CSF and plasma fibrinogen levels together with routine parameters in patients with multiple sclerosis (MS), acute inflammatory diseases of the CNS (bacterial and viral meningoencephalitis, BM and VM) and PNS (Guillain-Barré syndrome; GBS), as well as in non-inflammatory neurological controls (OND) in a total of 103 patients. Additionally, MS patients underwent cerebral MRI scans at time of lumbar puncture.CSF and plasma fibrinogen levels were significantly lower in patients with MS and OND patients as compared to patients with BM, VM and GBS. There was a close correlation between fibrinogen levels and albumin quotient (rho = 0.769, p < 0.001) which strongly suggests passive transfer of fibrinogen through the blood-CSF-barrier during acute inflammation. Hence, in MS, the prototype of chronic neuroinflammation, CSF fibrinogen levels were not elevated and could not be correlated to clinical and neuroradiological outcome parameters. Although previous work has shown clear evidence of the involvement of fibrinogen in MS pathogenesis, this is not accompanied by increased fibrinogen in the CSF compartment.
Imprenta: Fluids and Barriers of the CNS, v. 8, n. 1, p. 25, 2011
Identificador do objeto digital: 10.1186/2045-8118-8-25
Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Infectious diseases ; Guillain-Barre Syndrome - Inflammation
Data de publicação: 2011